Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

Cell Specific Gene Expression

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Two Commercially Available Blood-Stabilization Reagents Serve as Potent Inactivators of Coronaviruses.

Pathogens (Basel, Switzerland)·2023

Same author

Two-photon microendoscope for label-free imaging in stereotactic neurosurgery.

Biomedical optics express·2023

Same author

Excitable Axonal Domains Adapt to Sensory Deprivation in the Olfactory System.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2022

Same author

The Olfactory Bulb Facilitates Use of Category Bounds for Classification of Odorants in Different Intensity Groups.

Frontiers in cellular neuroscience·2020

Same author

Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid Arthritis.

Frontiers in immunology·2020

Same author

Human Islet Response to Selected Type 1 Diabetes-Associated Bacteria: A Transcriptome-Based Study.

Frontiers in immunology·2019

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

WS6 induces both alpha and beta cell proliferation without affecting differentiation or viability.

Brian P Boerner¹, Nicholas M George, Shakeel U R Mir

¹Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, USA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Endocrine Journal

|March 6, 2015

Summary

The small molecule WS6 stimulates proliferation of both human beta and alpha cells, crucial for diabetes mellitus treatment. It increases human islet mass without affecting cell differentiation or viability.

More Related Videos

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

Related Experiment Videos

Last Updated: Apr 16, 2026

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

Area of Science:

Endocrinology
Cell Biology
Regenerative Medicine

Background:

Diabetes mellitus treatment requires agents that stimulate human pancreatic beta cell proliferation.
The small molecule WS6 has shown potential by stimulating beta cell proliferation, but its broader effects on human islets are not well understood.

Purpose of the Study:

To conduct an in-depth phenotypic analysis of WS6-treated human islets.
To explore WS6's effects on non-beta cell proliferation, beta cell differentiation, and islet cell viability.
To evaluate WS6's potential as a beta cell regenerative therapy.

Main Methods:

Culturing human islets and treating them with WS6.
Performing phenotypic analysis to assess cell proliferation, differentiation, and viability.
Quantifying beta and alpha cell proliferation and assessing beta cell markers.

Main Results:

WS6 stimulated proliferation in both human beta cells and alpha cells, indicating it is not beta cell-specific.
WS6 did not alter beta cell differentiation, as evidenced by stable insulin-positive cell proportions and transcription factor expression.
WS6 had no adverse effects on human islet cell apoptosis or overall viability.

Conclusions:

WS6 promotes proliferation of both human beta and alpha cells.
WS6 maintains cellular viability and the differentiated phenotype of beta cells.
These findings support WS6's potential to increase human islet mass for diabetes treatment.